The Argatroban and Tissue-Type Plasminogen Activator Stroke Study Final Results of a Pilot Safety Study Article

Barreto, Andrew D, Alexandrov, Andrei V, Lyden, Pat et al. (2012). The Argatroban and Tissue-Type Plasminogen Activator Stroke Study Final Results of a Pilot Safety Study . STROKE, 43(3), 770-775. 10.1161/STROKEAHA.111.625574

Open Access International Collaboration

cited authors

  • Barreto, Andrew D; Alexandrov, Andrei V; Lyden, Pat; Lee, Jessica; Martin-Schild, Sheryl; Shen, Loren; Wu, Tzu-Ching; Sisson, April; Pandurengan, Renganayaki; Chen, Zhongxue; Rahbar, Mohammad H; Balucani, Clotilde; Barlinn, Kristian; Sugg, Rebecca M; Garami, Zsolt; Tsivgoulis, Georgios; Gonzales, Nicole R; Savitz, Sean I; Mikulik, Robert; Demchuk, Andrew M; Grotta, James C

sustainable development goals

authors

publication date

  • March 1, 2012

published in

keywords

  • ACUTE ISCHEMIC-STROKE
  • Argatroban
  • CEREBRAL THROMBOSIS
  • COHORT
  • Cardiovascular System & Cardiology
  • Clinical Neurology
  • EXPERIENCE
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Peripheral Vascular Disease
  • RECANALIZATION
  • Science & Technology
  • THERAPY
  • THROMBIN INHIBITOR ARGATROBAN
  • THROMBOLYSIS
  • TRANSCRANIAL DOPPLER
  • WINDOW
  • acute stroke
  • anticoagulation
  • thrombin inhibition
  • thrombolysis

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • 770

end page

  • 775

volume

  • 43

issue

  • 3